EUVIMEDEUVIMED entdecken
Crossref

Predictors of recurrence and survival in advanced papillary thyroid carcinoma: a retrospective cohort analysis

A K Lederer, A Fiedler, J I Staubitz-Vernazza, O Lozan, M O Metzig, H Lang, T J Musholt

British Journal of Surgery · 18.05.2026 · 113 (Supplement_3)

DOI: 10.1093/bjs/znag045.023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 18.05.2026. Verfasst von A K Lederer und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Papillary thyroid carcinoma (PTC) is the most common malignant thyroid tumour, with a subset of patients presenting with advanced disease. The ESES recently refined the definition of advanced thyroid cancer. This study aimed to characterize clinical features, treatment patterns, and outcomes of patients with advanced PTC according to the updated ESES definition at a high-volume endocrine surgery center.

Method

In this monocentric, retrospective cohort study, all patients undergoing primary surgery for advanced PTC at the University Medical Center Mainz between 2015 and 2024 were included.

Results

Thirty-three patients were analysed (median age 54 years, 52% male, median Charlson Comorbidity Index [CCI] 2). Among 27 patients disease-free after surgery, 10 (37%) experienced recurrence, predominantly in lymph nodes and lung. Median recurrence-free survival was 11.4 months, and median progression-free survival in patients not disease-free after surgery (n = 6) was 6.0 months. Age >55 years was significantly associated with poorer survival (p = 0.005), while higher CCI showed a trend (p = 0.077). Logistic regression identified age (p = 0.037) and CCI (p = 0.024) as individual predictors of non-survival, but neither remained significant in the combined model, likely due to correlation (r = 0.402, p = 0.021). Male sex showed a non-significant trend toward higher recurrence risk (p = 0.058).

Conclusion

In this small exploratory cohort, older age and higher comorbidity were associated with reduced survival. Despite recurrences, long-term outcomes appeared relatively favourable for most patients. Larger studies are needed to confirm predictors of survival and recurrence.

Zitieren

APA

Lederer, A. K., Fiedler, A., Staubitz-Vernazza, J. I., Lozan, O., Metzig, M. O., Lang, H., & Musholt, T. J. (2026). Predictors of recurrence and survival in advanced papillary thyroid carcinoma: a retrospective cohort analysis. British Journal of Surgery, 113(Supplement_3). https://doi.org/10.1093/bjs/znag045.023

Vancouver

Lederer AK, Fiedler A, Staubitz-Vernazza JI, Lozan O, Metzig MO, Lang H, et al. Predictors of recurrence and survival in advanced papillary thyroid carcinoma: a retrospective cohort analysis. British Journal of Surgery. 2026;113(Supplement_3). doi:10.1093/bjs/znag045.023

BibTeX
@article{Lederer2026,
  author = {Lederer, A K and Fiedler, A and Staubitz-Vernazza, J I and Lozan, O and Metzig, M O and Lang, H and Musholt, T J},
  title = {Predictors of recurrence and survival in advanced papillary thyroid carcinoma: a retrospective cohort analysis},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_3},
  doi = {10.1093/bjs/znag045.023}
}
Kostenlos starten →